Connecting healthcare and manufacturing: The challenges of COVID-19
There have been many challenges in matching the offers of support from the manufacturing community to respond to the COVID-19 crisis with the dynamic and uncertain needs of the healthcare system,...
View ArticleThe Future Fund offers welcome relief to innovative businesses
The UK Government has pledged to make up to £250 million available to innovative companies facing financial hardship as a result of the Coronavirus crisis, with the prospect of increased funds if...
View ArticleCoronavirus and the Mergers and acquisition market
The swift transition to a Covid-19 working environment and the economic uncertainty generated by that change has, understandably, had a big impact on the UK’s mid-market M&A scene, writes James...
View ArticleTokyo pharma backs Babraham startup accelerator
Eisai, the Tokyo-based global pharmaceutical powerhouse, is the latest world leader in its field to provide financial and mentoring support for the Accelerate@Babraham initiative in Cambridge.The...
View ArticleScientists say easy changes would cut transmission risk in COVID-19 hospitals
Low-cost ventilation designs allied to simpler configuration of wards can reduce the dispersal of airborne virus in emergency COVID-19 hospitals converted from large open spaces, say Cambridge...
View ArticleAstraZeneca nurses profits and patients in stunning first quarter
Cambridge Big Biotech AstraZeneca delivered a stunning performance in the first quarter of 2020 – combining dual roles as white knight to the healthcare community in the eye of the COVID-19 storm and...
View ArticleArm hands silicon startups free access to chip designs
Cambridge technology giant and social enterprise evangelist Arm has triggered a new era in silicon prototype development by offering startups in the sector free access to its chip designs – the most...
View ArticleThree Cambridge ventilator designs still in the mix to counter coronavirus...
One Cambridge technology consultancy has failed to make the cut and three others are sweating on Government decisions in the coming week on which projects will continue to be supported under the...
View ArticleCambridge professor’s latest spin-out aims to reduce microplastic pollution
Cambridge University spin-out, Xampla, dedicated to reduce microplastic pollution, has raised £2 million seed funding. The round was co-led by the university’s commercialisation arm Cambridge...
View ArticleAstraZeneca wings in to fast-track COVID-19 vaccine globally
Cambridge Big Biotech business AstraZeneca is teaming up with Oxford University to fast-track manufacture and distribution worldwide of a ‘Holy Grail’ COVID-19 vaccine.The collaboration aims to bring...
View ArticleAvacta and US partner developing antigen test to fight COVID-19
Cambridge UK life science technology business Avacta has joined forces with Adeptrix Corporation in Massachusetts to develop and manufacture a high throughput COVID-19 antigen test using Adeptrix’s...
View ArticleDarktrace primed for huge IPO
Cambridge-based cyber security world leader Darktrace continues to work towards an IPO – possibly in the US and UK – next year after growing its market capitalisation to more than $2 billion.Sources...
View ArticleCrisis generates new levels of innovation
In the current COVID-19 crisis, governments around the world are turning to businesses and research organisations in the life sciences sector to assist in meeting the challenge, writes James Fry,...
View ArticleReal estate in the context of the COVID-19 pandemic
It is perhaps unavoidable that this month’s column concentrates on the main issue on everyone’s mind – the current crisis in which we find ourselves, writes Will Mooney, Partner, Carter Jonas...
View ArticleCambridge ventilator designs jettisoned by the Government
Three Cambridge technology innovators have had government support for ventilator designs in which they were instrumental terminated following a further review.Cambridge Consultants, Sagentia and TTP...
View ArticlePot of gold for cannabis-based drug pioneer
GW Pharmaceuticals plc, which is pioneering medicines based on cannabis, has scaled fresh heights in terms of financial performance and advancement of treatments in the US and Europe in the first...
View ArticleThe evolution of offices for the future
The recent enforced changes in how we work as well as where we work raises questions as to how commercial office space will change in the future, writes Barnaby Clark, Sales and Marketing Director of...
View ArticleTime for the visionaries to shine
Ruth Logan, head of assurance at EY in Cambridge, describes the challenges companies are facing in the current crisis and how they are responding with entrepreneurialism, planning and positivity. In...
View ArticleThree per cent of NHS hospital staff may unknowingly have virus
Hospital staff could be carrying SARS-CoV-2, the coronavirus that causes COVID-19 disease, without realising they are infected, according to a study by Cambridge University researchers.Patients...
View ArticleFrontier Developments ‘hammers’ towards $billion milestone
UK video games company Frontier Developments is basking in an unprecedented surge that is taking it closer to the magical billion dollar valuation mark.Its share price has surged on the back of recent...
View Article